Clinical Trial Update: A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial of a tetravalent live attenuated dengue vaccine in dengue-naive infants completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Tetravalent live attenuated dengue vaccine

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-19